Search Results - "Krejci, M"

Effect of methane-dimethyl ether fuel blends on flame stability, laminar flame speed, and Markstein length by Lowry, W.B., Serinyel, Z., Krejci, M.C., Curran, H.J., Bourque, G., Petersen, E.L.

“…Binary fuel blends provide challenges to chemical kinetics models not seen by testing only pure fuels, allowing them to be proven over a wider range of inputs…”
Get full text

Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients by Stork, M, Sevcikova, S, Adam, Z, Krejci, M, Sandecka, V, Kral, Z, Brozova, L, Velichova, R, Pour, L

“…The combination of lenalidomide and dexamethasone is the current gold standard for treatment of relapsed multiple myeloma. This study analyzes the efficiency…”
Get more information

The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study by Valkova, V, Jircikova, J, Trnkova, M, Steinerova, K, Keslova, P, Lanska, M, Koristek, Z, Raida, L, Krejci, M, Kruntoradova, K, Dolezal, T, Benesova, K, Cetkovsky, P, Trneny, M

“…Although allogeneic haematopoietic stem cell transplantation (allo-HSCT) offers a unique curative potential, it may be connected with high treatment-related…”
Get more information

Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma--phase II study results by Zahradova, L, Mollova, K, Ocadlikova, D, Kovarova, L, Adam, Z, Krejci, M, Pour, L, Krivanova, A, Sandecka, V, Hajek, R

“…In a phase II clinical study, pretreated multiple myeloma patients with relapsing or stable disease received autologous anticancer vaccine containing dendritic…”
Get more information

Scleredema associated with multiple myeloma or MGUS: treatment report of four cases by Krejci, M, Adam, Z, Pour, L, Michalkova, E, Sandecka, V, Szturz, P, Kral, Z, Mayer, J

Get full text

Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host disease by Krejci, M, Kamelander, J, Pospisil, Z, Mayer, J

“…Graft-versus-host disease (GVHD) is the most frequent complication after allogeneic hematopoietic cell transplantation. We analyzed the kinetics of bilirubin…”
Get more information

212 TRANSFUSIONS AND PRESENCE OF RINGSIDEROBLASTS INFLUENCE HEPCIDIN AND NTBI LEVELS IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - A REPORT FROM THE EUROPEAN LEUKEMIANET MDS REGISTRY by de Swart, L, Reiniers, C, Bagguley, T, Van Marrewijk, C, Bowen, D, Cermak, J, Hellström-Lindberg, E, Tatic, A, Symeonidis, A, Huls, G, Panagiotidis, P, Garelius, H, Culligan, D, Krejci, M, Droste, J, Smith, A, Swinkels, D, de Witte, T

Get full text

Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse by HORKY, O., MAYER, J., KABLASKOVA, L., RAZGA, F., KREJCI, M., KISSOVA, J., BORSKY, M., JEZISKOVA, I., DVORAKOVA, D.

“…Summary Introduction:  The reoccurrence or increase in autologous hematopoiesis after allogeneic transplantation has been linked to incipient leukemia relapse…”
Get full text

Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients by KREJCI, M, BUCHLER, T, HAJEK, R, SVOBODNIK, A, KRIVANOVA, A, POUR, L, ADAM, Z, MAYER, J, VORLICEK, J

“…Autologous stem cell transplantation (ASCT) has an established role in the treatment of symptomatic multiple myeloma (MM). Our aim was to analyse the impact of…”
Get full text

Quality of life is an important factor in the balance sheet indicator in patients with pancreatic cancer. Multicentric prospective study by Ryska, M, Dusek, L, Pohnan, R, Bunganic, B, Bieberova, L, Ryska, O, Lovecek, M, Jon, B, Ruppert, K, Krejci, M, Jarkovsky, J

Get full text

Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation by Greslikova, H, Zaoralova, R, Filkova, H, Nemec, P, Oltova, A, Kupska, R, Rudolecka, P, Smetana, J, Pour, L, Zahradova, L, Krejci, M, Buchler, T, Adam, Z, Hajek, R, Kuglik, P

“…Malignant plasma cells in multiple myeloma (MM) are frequently characterized by complex karyotypes and chromosome instability. These cytogenetic changes are…”
Get more information

12.8% Efficiency Cu(In,Ga)Se2 solar cell on a flexible polymer sheet by Tiwari, A. N., Krejci, M., Haug, F.-J., Zogg, H.

“…A lift‐off process has been developed to obtain Cu(In,Ga)Se2 solar cells on flexible polymer sheets. The absorber layer is grown by a co‐evaporation method on…”
Get full text

Extraordinary response to erlotinib therapy in a patient with lung adenocarcinoma exhibiting KRAS mutation and EGFR amplification by Krejci, J, Pesek, M, Grossmann, P, Krejci, M, Ricar, J, Benesova, L, Minarik, M

“…Case reports on the co-incidence of Kirsten rat sarcoma (KRAS) mutation and epidermal growth factor receptor (EGFR) amplification in patients with NSCLC are…”
Get full text

Aging, hormones and receptors by Hill, M, Třískala, Z, Honců, P, Krejčí, M, Kajzar, J, Bičíková, M, Ondřejíková, L, Jandová, D, Sterzl, I

“…Ageing is accompanied by deterioration in physical condition and a number of physiological processes and thus a higher risk of a range of diseases and…”
Get full text

Prognostic significance of morphological assessment of plasma cells in multiple myeloma by Al-Sahmani, M, Trnavska, I, Sevcikova, S, Antosova, M, Antosova, L, Kissova, J, Adam, Z, Pour, L, Nemec, P, Greslikova, H, Krejci, M, Zahradova, L, Bulikova, A, Penka, M, Hajek, R

“…Multiple myeloma (MM) is a hematological malignancy caused by clonal proliferation of malignant plasma cells (PC). The aim of the work is to determine…”
Get more information

Reduction of Threading Dislocation Densities in Heavily Lattice Mismatched PbSe on Si(111) by Glide by Müller, P., Zogg, H., Fach, A., John, J., Paglino, C., Tiwari, A. N., Krejci, M., Kostorz, G.

Get full text

Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group by Krivanová, A, Hájek, R, Krejcí, M, Scudla, V, Indrák, K, Bacovský, J, Büchler, T, Svobodník, A, Adam, Z, Mayer, J, Vorlícek, J

“…High-dose chemotherapy followed by autologous stem cell transplantation (AT) is accepted as first-line therapy for patients with multiple myeloma (MM), with…”
Get more information

Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin by Krejci, M, Brychtova, Y, Doubek, M, Tomiska, M, Navratil, M, Racil, Z, Dvorakova, D, Horky, O, Lengerova, M, Pospisilova, S, Mayer, J

“…Reduced-intensity conditioning (RIC) is widely used for allogeneic stem cell transplantation (SCT). Here we present our long-term experience with RIC regimen…”
Get more information

P075 Characteristics of patients with therapy-related myelodysplastic syndrome by Belohlavkova, P, Voglova, J, Neuwirtova, R, Krejcova, H, Cermak, J, Vondrakova, J, Vozobulova, V, Krejci, M, Muzik, J

Get full text

Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia by KREJCI, M, MAYER, J, DOLEZAL, T, VORLICEK, J, DOUBEK, M, BRYCHTOVA, Y, POSPISIL, Z, RACIL, Z, DVORAKOVA, D, LENGEROVA, M, HORKY, O, KORISTEK, Z

“…A reduced-intensity conditioning allogeneic stem cell transplantation was given to 19 patients (aged 15-59 years) in the first chronic phase and one patient in…”
Get full text